[October 2024 Edition] REVIVO BioSystems at COSMETIC 360 in Paris  This past October we had a successful wrap-up of the COSMETIC 360...

[September 2024 Edition] New Insights into Skin Ageing with REVIVO BioSystems’ Chronological Ageing Skin Model Leveraging REVIVO...

[August 2024 Edition] Rele GO™ earns European & Korean Certifications REVIVO BioSystems' automated fraction collector, Rele GO ™, has...

[July 2024 Edition] Our unique 4D in vitro testing platform, Rele GO ™ & REV ex ™, provides you with solutions to the limitations of the...

[June 2024 Edition] REVIVO BioSystems' Standardised in vitro Pre-Wounded Model For pharmaceutical companies, biotech firms, and...

[May 2024 Edition] Understanding the Long-term Effects of Ingredients and Formulations Cosmetic and dermatological companies have long...

[April 2024 Edition] A Groundbreaking Achievement Preserving the viability of  native human skin explants is known to be a limiting...

[March 2024 Edition] Pioneering ethical innovation in China In the cosmetic industry, traditional practices in China have often included...

[February 2024 Edition] Exploring the Potential of India’s Consumer & Pharmaceutical Sectors In a recent visit to India, REVIVO...

[January 2024 Edition] How a 4D in vitro platform compares to 3D In the ever-evolving landscape of in vitro research, the transition from...

[December 2023 Edition] Remarkable 2023: REVIVO BioSystems’ highlights Looking back on 2023, we’d like to take the opportunity to reflect...

[November 2023 Edition] New kid on the block: in vitro oral barriers-on-chip for dental- and oral-care research We are thrilled to...

[October 2023 Edition] The Uniqueness of Our 4D In-Vitro Solutions Our dynamic 4D system is a remarkable innovation, featuring tiny...

[September 2023 Edition] Our Innovative Products In the realm of groundbreaking products, our ReleGO™️ & REVex™️ platform stands out for...

[August 2023 Edition] REVIVO BioSystems’ global expansion through strategic distributor partnerships The increasing global interest in...

[July 2023 Edition] Breakthrough Technology Showcase in July Throughout the busy and productive month of July, REVIVO BioSystems has...

[June 2023 Edition] The Potential of 4D Tissue Models in the Development of Skin Disease Treatments: A Conversation with Dr. Sebastien...

[May 2023 Edition] The three standout features of ReleGO™& REVex™ REVIVO BioSystems’ platform, ReleGO™ and REVex™, incorporates highly...

[April, 2023] Message from our CEO Dear Partners, At REVIVO Biosystems, we are still feeling tremendous excitement over the recent launch...

[March, 2023] ReleGO™ and REVex™ made a memorable debut 2 March 2023 marked a major milestone for REVIVO BioSystems when the official...